The new plasma-based diagnostic tool is intended to improve early detection of Alzheimer’s through a less invasive method. The U.S. Food and Drug Administration (FDA) has cleared the…
Read MorePlasma
FDA Approves Cell Therapy for Blood Cancer Patients
Cell therapy has the potential to reduce the risk of infection after stem cell transplants. The U.S. Food and Drug Administration (FDA) recently approved Omisirge (omidubicel-onlv), a donor-modified…
Read More
FDA’s Plasma Program Data Lacks Cohesion
Informal study hampered by greater than anticipated participation of COVID-19 patients. The U.S. Food and Drug Administration designed a plasma program to try and speed along potential research…
Read More